Gregory Mattingly, MD

News

Cariprazine for schizophrenia and bipolar I disorder

Author:

Gregory Mattingly, MD

Publish date: January 27, 2016

As a dopamine D3-preferring D3/D2 partial agonist, cariprazine offers an alternative to antipsychotics that preferentially modulate D2 receptors.

• Read More

News

Cariprazine for schizophrenia and bipolar I disorder

Author:

Gregory Mattingly, MD

Publish date: January 27, 2016

As a dopamine D3-preferring D3/D2 partial agonist, cariprazine offers an alternative to antipsychotics that preferentially modulate D2 receptors.

• Read More